About fulgent genetics inc - FLGT
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
FLGT At a Glance
Fulgent Genetics, Inc.
4399 Santa Anita Avenue
El Monte, California 91731
| Phone | 1-626-350-0537 | Revenue | 322.67M | |
| Industry | Medical/Nursing Services | Net Income | -60,513,000.00 | |
| Sector | Health Services | 2025 Sales Growth | 13.829% | |
| Fiscal Year-end | 12 / 2026 | Employees | 1,344 | |
| View SEC Filings |
FLGT Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 2.506 |
| Price to Book Ratio | 0.734 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -7.095 |
| Enterprise Value to Sales | 1.473 |
| Total Debt to Enterprise Value | 0.017 |
FLGT Efficiency
| Revenue/Employee | 240,082.589 |
| Income Per Employee | -45,024.554 |
| Receivables Turnover | 3.522 |
| Total Asset Turnover | 0.261 |
FLGT Liquidity
| Current Ratio | 6.479 |
| Quick Ratio | 6.479 |
| Cash Ratio | 3.955 |
FLGT Profitability
| Gross Margin | 38.071 |
| Operating Margin | -28.232 |
| Pretax Margin | -21.702 |
| Net Margin | -18.754 |
| Return on Assets | -4.899 |
| Return on Equity | -5.39 |
| Return on Total Capital | -5.403 |
| Return on Invested Capital | -5.36 |
FLGT Capital Structure
| Total Debt to Total Equity | 0.723 |
| Total Debt to Total Capital | 0.718 |
| Total Debt to Total Assets | 0.662 |
| Long-Term Debt to Equity | 0.516 |
| Long-Term Debt to Total Capital | 0.512 |